HCDC0001L102
Mobius Gold High Cell Density Cryopreservation Assembly
(-80C), 250 mL, sterile; γ-irradiated (at 25-40 kGy)
别名:
Mobius® Gold High Cell Density Cryopreservation Assembly (-80C), 250 mL
物料
C-Flex® tubing (374)
device (thermoplastic elastomer)
polyethylene device
polypropylene device
silicone device
tubing (Pharma 65)
质量水平
Agency
according to ISO 11137
meets EN 2.6.14
meets JP 4.01
meets USP 85
无菌性
sterile; γ-irradiated (level of 25-40 kGy)
产品线
Mobius®
包装
package of 5 ×
参数
-80-60 °C temp. range (-112-140 °F)
0.3 bar max. pressure (4.4 psi)
150 mL process volume
技术
buffer exchange: suitable
media fill: suitable
容量
250 mL
杂质
<0.25 EU/mL Aqueous extraction (LAL test)
配件
plug (plug-end 1/8"HB)
port (end-ported 2x 1/8"HB)
应用
cell therapy
gene therapy
life science and biopharma
liquid processing
mAb
ophthalmics
parenterals
pharma/biopharma processes
viral therapy
waste management
储存温度
2-30°C
正在寻找类似产品? 访问 产品对比指南
一般描述
Our Mobius® High Cell Density Cryopreservation (HCDC) Assembly (-196C) is a single-use assembly specially designed to facilitate the freeze and thaw of cryopreserved cells in liquid nitrogen vapor phase (? -196°C). Available in two assembly bag sizes of 100 mL and 250 mL, our Mobius® HCDC Assembly (-196C) enables seed train inoculation with cells at a higher cell density and larger volume compared to the traditional seed train process using vials, which significantly accelerates the cell expansion process. Our Mobius® single-use assembly also provides a closed processing environment preventing contamination while improving process reproducibility.
应用
生化/生理作用
Application
包装
其他说明
Pinch clamp: Nylon
法律信息
法规信息
商品
Understand how considerations such as DMSO concentrations and freezing techniques are key in the successful implementation of high cell density cryopreservation (HCDC).
High cell density cryopreservation (HCDC) is a closed processing alternative to the traditional seed train expansion process. Learn more about the benefits of HCDC.
This page provides an overview of USP <87>, <88>, and <1031>, compares bioreactivity testing, and describes the transition of our organization towards in vitro test methods.
相关内容
生物制药开发商需要高效、高产的上游工艺来提供优质的单克隆抗体(mAb)和其他类型重组蛋白。工艺强化可确保生产策略适应未来发展需求、降低成本并提升设施灵活性。
Biopharmaceutical developers need efficient, productive upstream processes that deliver high quality monoclonal antibodies (mAbs) and other types of recombinant proteins. Process intensification can future-proof their manufacturing strategies, reduce costs, and increase facility flexibility.
Learn more about cell culture media development for mAB development and manufacturing, and the products you need for this step.
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持